FSPM — Fusion Pharm Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.27m
- $0.81m
Annual income statement for Fusion Pharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1995 September 30th | 1996 September 30th | 1997 September 30th | 2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | ARS | ARS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.28 | 7.99 | 0.883 | 0.227 | 0.808 |
| Cost of Revenue | |||||
| Gross Profit | -0.237 | -1.1 | -2.09 | 0.069 | 0.676 |
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.72 | 10.7 | 3.17 | 0.619 | 0.516 |
| Operating Profit | -1.45 | -2.66 | -2.29 | -0.392 | 0.292 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.45 | -2.26 | -0.871 | -0.402 | 0.265 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.16 | -2.28 | -0.883 | -0.402 | 0.265 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.16 | -2.28 | -0.883 | -0.402 | 0.265 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -1.16 | -2.28 | -0.883 | -0.402 | 0.265 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -11.5 | -17.4 | -6.83 | -0.159 | 0.106 |
| Dividends per Share |